Peripheral Arteriopathy Rate In Stroke (PARIS)
October 24, 2017 updated by: University of Erlangen-Nürnberg Medical School
Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients
Purpose:
To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.
Interventions:
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
Design:
Prospective, open, cohort study.
Study size planned:
1500.
Follow-up duration:
3 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erlangen, Germany, 91054
- Department of Neurology, University of Erlangen, Germany
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
consecutive patients with acute ischemic or hemorhagic stroke.
Description
Inclusion Criteria:
- All consecutive adult patients with acute ischemic or hemorrhagic stroke.
Exclusion Criteria:
- Congestive heart failure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
TIA
|
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
|
|
2
Ischemic stroke
|
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
|
|
3
Hemorrhagic stroke
|
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Functional outcome (modified Rankin Scale)
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of peripheral arterial disease
Time Frame: during hospital stay
|
Presence or not of PAD as assessed using ABI during hospital stay
|
during hospital stay
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Stefan Schwab, MD, Head of the Department of Neurology, University of Erlangen, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
October 23, 2017
Study Completion (Actual)
October 23, 2017
Study Registration Dates
First Submitted
November 18, 2008
First Submitted That Met QC Criteria
November 18, 2008
First Posted (Estimate)
November 19, 2008
Study Record Updates
Last Update Posted (Actual)
October 25, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PARIS-Study2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.